pharmaceuticals
pharmaceuticals Articles
Here, 24/7 Wall St. includes a calendar of a few of the biggest companies expecting clinical trial and FDA updates in the rest of September and in October.
Published:
Last Updated:
The August 30 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks was mixed.
Published:
Last Updated:
After Lexicon Pharmaceuticals announced the termination of its alliance with Sanofi, its shares rallied on Wednesday.
Published:
Last Updated:
Eli Lilly shares dipped on Monday after the firm announced results from its midstage clinical trial for the treatment of lung cancer.
Published:
Last Updated:
Acadia Pharmaceuticals shares rose sharply early Monday after the firm announced that its late-stage dementia study met its primary endpoint.
Published:
Last Updated:
American opinions about most large industries are positive to neutral, according to a new study. While these opinions often change, it is rare that they are almost completely negative for any single...
Published:
Last Updated:
Mallinckrodt is a pharmaceutical player that has been in trouble over its role in the opioid crisis in America. Investors have to wonder if the worst outcome is in the making.
Published:
Last Updated:
Johnson & Johnson is trading higher on the news, but some smaller public companies tied into the opioid crisis are taking it on the chin.
Published:
Last Updated:
The August 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Published:
Last Updated:
One sector that has avoided much of the current trade and recession fear turmoil is health care, and especially the biotech companies. The four top stocks have gigantic implied upside.
Published:
Last Updated:
Vanda Pharma shares dropped early to start out the week after the frim announced that it received a Complete Response Letter from the FDA.
Published:
Last Updated:
Eli Lilly shares made a handy gain on Tuesday after the firm announced results from its late-stage study for the treatment of moderate to severe plaque psoriasis.
Published:
Last Updated:
24/7 Wall St. has evaluated all pharmaceutical and biotech companies that pay dividend yields above 2% based on their current prices.
Published:
Last Updated:
The July 31 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
Published:
Last Updated:
GlycoMimetics shares were crushed on Monday after the firm announced late-stage results from its sickle cell disease trial in conjunction with Pfizer.
Published:
Last Updated: